AU Stock MarketDetailed Quotes

ATXOA Amplia Therapeutics Ltd

Watchlist
  • 0.021
  • 0.0000.00%
20min DelayMarket Closed Feb 27 15:32 AET
8.15MMarket Cap0.00P/E (Static)

About Amplia Therapeutics Ltd Company

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Company Profile

SymbolATXOA
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Websitehttps://www.ampliatx.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067 03 9415 4000

Company Executives

  • Name
  • Position
  • Salary
  • Christopher John Burns
  • Non Executive Director,Chief Executive Officer,Managing Director
  • --
  • Warwick Bonner Tong
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Robert Peach
  • Non-Executive Director
  • --
  • Jane Catherine Bell
  • Non-Executive Director
  • --

Trending Stocks

ASX High Dividend ASX High Dividend
No. Symbol Price
Rio Tinto Ltd
RIO
117.500
Telstra Group Ltd
TLS
4.210
BHP Group Ltd
BHP
39.540
4
Origin Energy Ltd
ORG
10.510
5
CommBank
CBA
156.390
Log In for the Full List
Unlock Now